Moreover, the results from DSS analysis indicate that high expression of RARA-AS1 is also associated with poorer survival in Colon adenocarcinoma (COAD), GBM, Kidney renal clear cell carcinoma (KIRC), LGG, Stomach adenocarcinoma (STAD), and UVM, while the opposite trend is observed in KIRP, SARC, and THYM (Fig. 3B). Here, RARA is linked to glioblastoma.